CALGB SWOG 80702 results to be presented today. First large scale predictive Signatera data in CRC showing benefit to adding celecoxib to SOC ACT in S3 disease. Big news for field, congrats to all involved. @natera #alliance #GI24 #ctdna $ntra
natera.com/company/news/n…
natera.com/company/news/n…